+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

125I-Clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosis



125I-Clq-binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosis



Journal of Pediatrics 29(2): 215-222



We studied the incidence and levels of circulating immune complexes by the 125I-Clq-binding assay in patients with cystic fibrosis in relation to clinical respiratory status and specific IgG and IgE antibodies to Pseudomonas aeruginosa. Staphylococcus aureus, Aspergillus fumigatus, and Candida albicans. Overall prevalence of CIC was 43%, but 86% of serially studied patients had evidence of CIC at some time. Patients with acute respiratory exacerbations and deteriorating pulmonary function had a higher incidence of CIC (76%) as compared to stable patients (36%, P less than 0.01), as well as significantly higher levels of CIC. Acute exacerbations were also associated with significant increases in IgG antibody to Pseudomonas (P less than 0.005) but not in other antibodies. CIC did not correlate with Pseudomonas-specific IgG nor with any other specific antibody studied. A variety of age-related differences in specific antibody levels were seen. The episodic appearance of CIC is common in CF and is usually associated with exacerbation of lung disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 000803272

Download citation: RISBibTeXText

PMID: 7252678

DOI: 10.1016/s0022-3476(81)80453-2


Related references

Iodine 125 labeled complement c 1q binding and specific antibodies as indicators of pulmonary disease activity in cystic fibrosis. Journal of Pediatrics 99(2): 215-222, 1981

Rehabilitation in patients with chronic respiratory disease other than chronic obstructive pulmonary disease: exercise and physical activity interventions in cystic fibrosis and non-cystic fibrosis bronchiectasis. Respiration; International Review of Thoracic Diseases 89(3): 181-189, 2015

Studies on cystic fibrosis using isoelectric focusing. IV. Distinction between ciliary dyskinesia activity in cystic fibrosis and asthmatic sera and association of cystic fibrosis protein with the activity in cystic fibrosis serum. Pediatric Research 11(4): 317-324, 1977

Specific secretory antibodies in patients with cystic fibrosis abstract pseudomonas aeruginosa pulmonary infection. Bacteriological Proceedings 69: 87-88, 1969

Impaired opsonic activity of specific pseudomonas antibodies from cystic fibrosis subjects. American Review of Respiratory Disease 121(4 Suppl.): 68, 1980

Binding of 125I-labeled proteinases to plasma proteins in cystic fibrosis. Pediatric Research 13(9): 1030-1036, 1979

Increased [125I]trypsin-binding in serum from cystic fibrosis patients. Journal of Pediatric Gastroenterology and Nutrition 1(3): 345-348, 1982

A modified crossed radioimmunoelectrophoretic method for determination of allergen-specific IgG antibodies. Elimination of non-specific binding by use of F(ab')2-fragments of rabbit antibodies and 125I-labelled protein A. Allergy 39(2): 135-140, 1984

Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis. American Journal of Respiratory Cell and Molecular Biology 27(5): 619-627, 2002

Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report. Journal of Medical Case Reports 4: 117, 2010

Cystic Fibrosis Transmembrane Conductance Regulator. Implications in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 13(Suppl. 2): S150-S155, 2016

Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease. New England Journal of Medicine 323(24): 1685-1689, 1990

Correlation between specific IgG subclass antibodies to Pseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis. Pediatric Pulmonology 17(1): 31-40, 1994

Circulating Indicators of Free Radical Activity in Idiopathic Pulmonary Fibrosis (Ipf) - Do They Monitor Disease Activity?. Clinical Science 85(S29): 14p.1-14p, 1993

Validation of the Italian version of the Cystic Fibrosis Quality of Life Questionnaire (CFQoL), a disease specific measure for adults and adolescents with cystic fibrosis. Journal of Cystic Fibrosis 7(2): 116-122, 2008